Acular LS Interactions
There are 74 drugs known to interact with Acular LS (ketorolac ophthalmic), along with 2 disease interactions. Of the total drug interactions, 73 are moderate, and 1 is minor.
- View all 74 medications that may interact with Acular LS
- View Acular LS disease interactions (2)
Most frequently checked interactions
View interaction reports for Acular LS (ketorolac ophthalmic) and the medicines listed below.
- Abilify (aripiprazole)
- acetazolamide
- allopurinol
- Alrex (loteprednol ophthalmic)
- aspirin
- Augmentin (amoxicillin / clavulanate)
- Avodart (dutasteride)
- Azasite (azithromycin ophthalmic)
- bupropion
- Celebrex (celecoxib)
- Ciloxan (ciprofloxacin ophthalmic)
- clonazepam
- Cosopt (dorzolamide / timolol ophthalmic)
- Coumadin (warfarin)
- Crestor (rosuvastatin)
- Diovan HCT (hydrochlorothiazide / valsartan)
- doxazosin
- doxycycline
- Effexor XR (venlafaxine)
- etodolac
- Istalol (timolol ophthalmic)
- ketoconazole topical
- Klonopin (clonazepam)
- lisinopril
- Lyrica (pregabalin)
- Nexium (esomeprazole)
- Restasis (cyclosporine ophthalmic)
- simvastatin
- Vigamox (moxifloxacin ophthalmic)
- Zymar (gatifloxacin ophthalmic)
Acular LS disease interactions
There are 2 disease interactions with Acular LS (ketorolac ophthalmic) which include:
Report options
QR code containing a link to this page
More about Acular LS (ketorolac ophthalmic)
- Acular LS consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: ophthalmic anti-inflammatory agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.